UK biotech sector gets to work on manifesto for life sciences

2 September 2013

Work to gather sector views for the development of a Life Science Manifesto for the 2015-20 Parliament is well underway as part of the collaboration bringing together the UK’s BioIndustry Association (BIA), Bionow, BioPartner UK and One Nucleus.

The Life Science manifesto 2015-20 project will seek views from companies and organizations from across the UK to develop the key sector asks and needs for the next Parliament. Experience has shown time and again - most recently with the successful campaign for the continuation of the Biomedical Catalyst scheme - that a unified and coherent sector voice is most powerful and effective in achieving results and positive change.

The Life Science Manifesto project will enable the life science sector to take stock, assess the current environment and identify the key policy opportunities and challenges in the years ahead to reflect to policymakers. It is inclusive and UK-wide with numerous opportunities for engagement including voting with ballot papers on key policy issues at the following events this year which will provide an early platform to get involved:

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Biotechnology